Home › Cancro del polmone non a piccole cellule › Washington › Tacoma
Studi clinici su Cancro del polmone non a piccole cellule a Tacoma, WA
20 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Tacoma e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
In reclutamentoFase 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · a 8 mi di distanza
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · a 8 mi di distanza
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
In reclutamentoFase 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · a 26 mi di distanza
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · a 26 mi di distanza
- American Oncology Network Vista Oncology Division-East office, Olympia · a 26 mi di distanza
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
In reclutamentoFase 3
- Vista Oncology Inc PS, Olympia · a 26 mi di distanza
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- American Oncology Network Vista Oncology Division-West office, Olympia · a 26 mi di distanza
- American Oncology Network Vista Oncology Division-East office, Olympia · a 26 mi di distanza
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- Vista Oncology, Olympia · a 26 mi di distanza
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
In reclutamentoFase 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- Northwest Medical Specialties (NWMS), Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
In reclutamentoFase 3
- Local Institution - 0499, Lacey · a 23 mi di distanza
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Tacoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Research Site, Tacoma
- Research Site, Olympia · a 26 mi di distanza
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · a 26 mi di distanza
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
In reclutamentoFase 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · a 8 mi di distanza
- e altri 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
In reclutamentoFase 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · a 8 mi di distanza
- MultiCare Regional Cancer Center, Puyallup · a 8 mi di distanza
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 2
- USA09-0, Puyallup · a 8 mi di distanza
BostonGene and Exigent Genomic INsight Study
In reclutamentoStudio osservazionale
- Northwest Medical Specialities, Puyallup · a 8 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Tacoma
- Cancro al seno18 studi
- Colite ulcerosa15 studi
- Mieloma multiplo13 studi
- Cancro alla prostata11 studi
- Malattia di Crohn11 studi
- Cancro metastatico9 studi
- Cancro colorettale9 studi
- Melanoma7 studi
- Cancro ovarico7 studi
- Cancro (tutti i tipi)6 studi
- Cancro pancreatico6 studi
- Obesità6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.